Light Mode
$19.51 ↓ -0.15 (-0.74%) Trading Down from the previous close of $19.66, $0.18 below the day’s high of $19.69
+11.70 (+146.80%) / 6M
Momentum, market sentiment, and recent alerts
SLN reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +173.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.